3D Occlusion Disc Structure for Stable Vascular Apposition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing occlusion devices with two-dimensional discs risk partial slippage into vascular abnormalities, leading to stagnant blood flow and increased risk of device-related thrombosis (DRT).
Innovation Solution
A medical device with a three-dimensional disc design providing increased depth and material apposition against tissue, ensuring a smooth transition and minimizing stagnant blood flow.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If a two-dimensional disc design is used, then the device structure is simple and easy to manufacture, but the disc may slip into the vascular abnormality causing stagnant blood flow
Solution Approach 1:
The patent transitions from a two-dimensional disc design to a three-dimensional disc design by adding depth in the radial direction. This dimensional change allows the disc to achieve better apposition against the tissue walls surrounding the vascular abnormality, preventing slippage while maintaining manufacturability through techniques like radial expansion or self-expanding frames.
2Reliability
If a three-dimensional disc design is used, then blood flow uniformity is improved and DRT risk is reduced, but the device structure becomes more complex
Solution Approach 1:
The three-dimensional disc is constructed using a segmented approach with a frame structure that can be radially expanded or self-expanding. The disc comprises multiple components including a proximal surface, distal surface, and connecting framework, allowing complex geometry to be achieved through assembly of simpler elements rather than monolithic manufacturing.
3Reliability
If increased disc depth is used, then material apposition against tissue is improved, but the device size increases
Solution Approach 1:
The disc employs dynamic characteristics through radial expandability or self-expanding mechanisms. The device is delivered in a compressed state with reduced volume, then expanded at the target site to achieve the optimal three-dimensional shape and depth for tissue apposition. This allows the device to achieve large apposition depth without permanently occupying large vascular space.
Data Source
AI summary
Described herein is a medical device for treating a target site. The medical device includes a proximal end including a disc and a distal end including a lobe. The disc and lobe are connected by a connecting member. The disc includes a proximal surface, a distal surface, and a central surface extending between and connecting the proximal surface and distal surface, wherein the central surface separates the proximal surface from the distal surface by a predetermined depth distance.


